Effects of CI on Tinnitus and Its Symptoms
Launched by CHINESE PLA GENERAL HOSPITAL · Jul 6, 2022
Trial Information
Current as of November 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how a special type of electrical stimulation, delivered through cochlear implants, affects tinnitus, which is a ringing or buzzing sound in the ears that many people experience. Researchers believe that this stimulation might help reduce the unusual activity in the brain that causes tinnitus. By using a new brain scanning technique called electroencephalogram (EEG), the study aims to identify where tinnitus originates and understand how the electrical stimulation works to inhibit it.
To be eligible for this trial, participants should be between 16 and 90 years old and must have received a cochlear implant at a specific hospital in China. They should either have had tinnitus for at least three months or have no tinnitus at all. This study is significant because many people with cochlear implants also experience tinnitus, and understanding how to treat it could greatly improve their quality of life. Participants can expect to contribute to important research that may lead to better treatment options for tinnitus in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. This study included patients who received cochlear implants at the Auditory Implant Center of the Otorhinolaryngology-Head and Neck Surgery, China PLA General Hospital;
- • 2. The patients ranged from 16 to 90 years old;
- • 3. The patient experienced hearing loss and had either tinnitus longer than 0.25 years (experimental group 1) or no tinnitus (control group 2) before the cochlear implant surgery;
- • 4. The cochlear implants accepted by patients included products from MED-EL, Cochlear, Advanced Bionics and Nurotron;
- • 5. All patients voluntarily participated in the study.
- Exclusion Criteria:
- • 1 Tinnitus types exclude non otogenic tinnitus (including tinnitus caused by hypertension, heart disease, hyperthyroidism, neurasthenia, hyperlipidemia, etc.);
- • 2 Contraindications of cochlear implant surgery (refer to the guidelines for cochlear implant 2013 of the Chinese Medical Association);
- • 3 Intellectual deficiency
About Chinese Pla General Hospital
The Chinese PLA General Hospital, a prominent military medical institution in Beijing, serves as a leading sponsor for clinical trials, focusing on advancing healthcare through innovative research and development. Renowned for its comprehensive medical services and cutting-edge research capabilities, the hospital is committed to improving patient outcomes through rigorous scientific investigation and collaboration with various stakeholders in the healthcare sector. With a multidisciplinary approach and a strong emphasis on evidence-based practices, the Chinese PLA General Hospital aims to contribute significantly to the global medical community by facilitating the development of safe and effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, France, China
Patients applied
Trial Officials
Shi m Yang, M.D., Ph.D.
Study Director
Chinese PLA General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials